Intrinsic Value of S&P & Nasdaq Contact Us

Neuronetics, Inc. STIM NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
+475.5%

Neuronetics, Inc. (STIM) reported total assets of $141.55M and total liabilities of $115.31M for quarter ending 2025-12-31, resulting in total equity of $26.24M.

The company held $34.36M in cash and short-term investments. Total debt stood at $90.3M, with net debt of $56.17M. The Debt-to-Equity (D/E) ratio was 3.44 (leveraged).

Current ratio is 2.02, indicating strong short-term liquidity. Interest coverage is -2.1x (weak).

Criteria supported by this page:

  • HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (36/100) — Total assets $141.55M and equity $26.24M support the company's competitive scale
  • VALUE (100/100) — Debt-to-Equity 3.44 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 46/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
36/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Neuronetics, Inc. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $141.55M$145.47M$134.65M$141.99M
Total Liabilities $115.31M$114.11M$103.14M$102.46M
Total Debt $90.3M$90.75M$80.66M$82.54M
Cash & Investments $34.36M$34.65M$17.65M$20.43M
Total Stockholders Equity $22.38M$27.36M$27.15M$35.45M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message